반응식
C(O[C:4](=[O:11])[CH2:5][C:6](=O)[CH:7]([CH3:9])[CH3:8])C.Cl.[Cl:13][C:14]1[CH:15]=[C:16]([CH:20]=[C:21]([Cl:23])[CH:22]=1)[C:17]([NH2:19])=[NH:18]>>[Cl:13][C:14]1[CH:15]=[C:16]([C:17]2[N:19]=[C:4]([OH:11])[CH:5]=[C:6]([CH:7]([CH3:8])[CH3:9])[N:18]=2)[CH:20]=[C:21]([Cl:23])[CH:22]=1참가 물질
3
실험 절차
The title compound was prepared from 4-methyl-3-oxo-pentanoic acid ethyl ester and 3,5-dichloro-benzamidine hydrochloride according to general procedure 1. 1H NMR (DMSO-d6, 400 MHz) δ 1.20-1.26 (m, 6H), 2.80-2.90 (m, 1H), 6.34 (s, 1H), 7.82(s, 1H), 8.18 (s, 2H), 12.50 (br s,1H); MS: m/z (ESI) 283 (M+H).
출처 및 근거
- ORD 기록
- ord-ca265c6ccff24dba8fa31f56fa64f6aa
- 출처 데이터셋
- uspto-grants-2008_09
- 특허 번호
- US07423044B2
연결된 노트
불러오는 중…